Article: Deals

GenPat77 + BMBF Grant = Inflammatory Bowel Study

The Federal Ministry for Education and Research (BMBF) in Bonn, Germany has awarded funding to GenPat77 to support development of GenPat77's immunomodulator program in inflammatory bowel disease, CEACAMI,and for selection of the most promising biological therapeutic for clinical use. The award was dispersed as part of the BioChancePLUS support program, which assists small and medium-sized biotech companies in developing and implementing biotech processes and products.

TorreyPines Therapeutics+ Eisai = Alzheimer's Research

A joint research program has been formed between Torrey Pines Therapeutics and Eisai Co. Ltd., focusing on the discovery ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!